This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2020 Oct;17(10):1118.

doi: 10.1038/s41423-020-00537-z.

Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us

Dieter Kabelitz¹, Ruben Serrano², Léonce Kouakanou², Christian Peters², Shirin Kalyan³

Affiliations

Affiliations

¹ Institute of Immunology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein Campus Kiel, D-24105, Kiel, Germany. dietrich.kabelitz@uksh.de.
² Institute of Immunology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein Campus Kiel, D-24105, Kiel, Germany.
³ Faculty of Medicine, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.

PMID: 32873864
PMCID: PMC7608082
DOI: 10.1038/s41423-020-00537-z

Published Erratum

Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us

Dieter Kabelitz et al. Cell Mol Immunol. 2020 Oct.

. 2020 Oct;17(10):1118.

doi: 10.1038/s41423-020-00537-z.

Authors

Dieter Kabelitz¹, Ruben Serrano², Léonce Kouakanou², Christian Peters², Shirin Kalyan³

Affiliations

¹ Institute of Immunology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein Campus Kiel, D-24105, Kiel, Germany. dietrich.kabelitz@uksh.de.
² Institute of Immunology, Christian-Albrechts University of Kiel and University Hospital Schleswig-Holstein Campus Kiel, D-24105, Kiel, Germany.
³ Faculty of Medicine, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.

PMID: 32873864
PMCID: PMC7608082
DOI: 10.1038/s41423-020-00537-z

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

PubMed Disclaimer

Erratum for

Cancer immunotherapy with γδ T cells: many paths ahead of us.
Kabelitz D, Serrano R, Kouakanou L, Peters C, Kalyan S. Kabelitz D, et al. Cell Mol Immunol. 2020 Sep;17(9):925-939. doi: 10.1038/s41423-020-0504-x. Epub 2020 Jul 22. Cell Mol Immunol. 2020. PMID: 32699351 Free PMC article. Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources